ICAN: Improving Cognition After Cancer

Sponsor
University of California, San Diego (Other)
Overall Status
Recruiting
CT.gov ID
NCT04049695
Collaborator
(none)
250
1
2
52.8
4.7

Study Details

Study Description

Brief Summary

This study will test whether a physical activity intervention can improve cognition in breast cancer survivors and help the development of physical activity guidelines for cognition in breast cancer survivors.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Exercise
  • Behavioral: Control
N/A

Detailed Description

Many breast cancer survivors experience problems with mental abilities such as memory, attention, and concentration (known as cognition). Increasing physical activity has been shown to improve cognition in adults; however, little is known about whether this is helpful for cancer survivors as well. This study will test whether a physical activity intervention can improve cognition in breast cancer survivors and help the development of physical activity guidelines for cognition in breast cancer survivors.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
250 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Randomized Trial of Physical Activity for Cognitive Functioning in Breast Cancer Survivors
Actual Study Start Date :
Sep 9, 2019
Anticipated Primary Completion Date :
Feb 1, 2024
Anticipated Study Completion Date :
Feb 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Exercise Intervention

This arm will receive a 12-month individually tailored phone and email-based exercise program.

Behavioral: Exercise
This intervention is based on Control Theory and Social Cognitive Theory and includes: 1) weekly emails with tips and tools to set personalized exercise goals and to increase exercise; 2) Health coaching phone sessions; 3) wrist worn monitor such as a Fitbit to track activity

Active Comparator: Health & Wellness Intervention

This arm will receive a 12-month health and wellness program.

Behavioral: Control
This intervention includes: 1) weekly emails with tips and tools to support health and wellness such as brain health, stress management, nutrition; 2) Health coaching phone sessions

Outcome Measures

Primary Outcome Measures

  1. National Institutes of Health Toolbox - Cognition Domain - Oral Symbol Digital Test [Baseline to 6 months]

    Measure of processing speed

Secondary Outcome Measures

  1. National Institutes of Health Toolbox - Cognition Domain - Oral Symbol Digital Test [Baseline to 12 months]

    Measure of processing speed

  2. Patient Reported Outcomes Measurement Information System (PROMIS) cognitive abilities [Baseline to 6 months and Baseline to 12 months]

    Measure of Self-Report Cognition

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • breast cancer survivors who have completed active treatment at least 6 months prior to enrollment and are within 5 years of diagnosis of stage 1, 2, or 3 breast cancer

  • self-report difficulties with cognition since their cancer diagnosis

  • self-report low levels of moderate to vigorous physical activity

  • have a Fitbit compatible device with internet

  • breast cancer was treated with chemotherapy and/or hormonal therapy

Exclusion Criteria:
  • medical condition that could make it potentially unsafe to be in an unsupervised physical activity intervention

  • currently taking tamoxifen or aromatase inhibitor that will be stopped in the next 6 months

  • unable to commit to a 12-month study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Moores UCSD Cancer Center La Jolla California United States 92093

Sponsors and Collaborators

  • University of California, San Diego

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sheri Hartman, Assistant Professor, University of California, San Diego
ClinicalTrials.gov Identifier:
NCT04049695
Other Study ID Numbers:
  • 182113
First Posted:
Aug 8, 2019
Last Update Posted:
Jan 27, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 27, 2022